Jian Cao

Medtronic

Topic

Bio

Jian Cao is a seasoned R&D leader with over 20 years of experience in the medical device industry, specializing in the development of cutting-edge implantable cardiac technologies. He has successfully led projects from initial concept through human clinical studies to global commercialization. Currently, he serves as the Research Program Director and Technical Fellow at Medtronic Cardiac Rhythm Management Research, focusing on insertable cardiac monitors, implantable pacemakers, and defibrillators.
Jian holds a Ph.D. in Biomedical Engineering from Penn State University, where he was recognized as an Outstanding Engineering Alumni. He also earned an Advanced Certificate for Executives from MIT Sloan School of Management. An accomplished innovator, he is the holder of 50+ issued U.S. patents and was honored with the Medtronic Patent of Distinction Award in 2019.

Abstract

Jian will share the evolution of Medtronic’s Reveal LINQ Insertable Cardiac Monitor (ICM), highlighting its impact on syncope detection and atrial fibrillation (AF) diagnosis and monitoring. Since pioneering the world’s first ICM in 1998, Medtronic has continually advanced the technology—achieving miniaturization, simplified in-office implantation, and eliminating the need for pre-implant ECG mapping. In 2021, Medtronic introduced AccuRhythm AI, a new artificial intelligence solution that significantly reduces false alerts and improves information accuracy. As the first FDA-cleared AI-powered technology from Medtronic, AccuRhythm AI was recognized with the 2023 MedTech Breakthrough Award for Best New Monitoring Solution.